Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasionHanan S. Elsarraj, Fariba Behbod, Marilee McGinness et al.|Breast Cancer Research|2015Cited by 46
Carboplatin (AUC 5) with oral vinorelbine (VNR) d 1,8 at 50 mg/m2 (level 1, L1) or 60 mg/m2 (level 2, L2) every 3 weeks: A phase I studyNikunj Patel, Franco M. Muggia, Samantha Moore et al.|Journal of Clinical Oncology|2005Cited by 1
Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasionP. Thomas, Andrew K. Godwin, Moriah R. Beck et al.|UNC Libraries|2019Cited by 0
Additional file 11: of Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasionHanan S. Elsarraj, Fariba Behbod, Yan Hong et al.|Figshare|2015Cited by 0
Additional file 3: of Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasionHanan S. Elsarraj, Fariba Behbod, Yan Hong et al.|Figshare|2015Cited by 0